Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [clinicaltrials:NCT00016601]
Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [clinicaltrials:NCT00016601]
Bio2RDF identifier
NCT00016601
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00016601
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... ions
are used together.
brief title [clinicaltrials_vocabulary:brief-title]
Depo-Medroxyprogesterone Aceta ...... IV Drugs in HIV-Infected Women
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2004-05-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
DMPA, an injectable dep ...... n are performed periodically.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-05-18T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anti-HIV Agents
Delayed-Action Preparations
Drug Interactions
Drug Therapy, Combination
HIV Protease Inhibitors
Medroxyprogesterone 17-Acetate
Nelfinavir
Nevirapine
Pharmacokinetics
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-10-31T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00016601
official title [clinicaltrials_vocabulary:official-title]
An Open-Label, Non-Randomized ...... apies Among HIV-Infected Women
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
secondary id [clinicaltrials_vocabulary:secondary-id]
ACTG A5093
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2001-06-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-10-01T00:00:00Z
identifier
clinicaltrials:NCT00016601
title
Depo-Medroxyprogesterone Aceta ...... IV Drugs in HIV-Infected Women
@en
type
label
Depo-Medroxyprogesterone Aceta ...... n [clinicaltrials:NCT00016601]
@en